Inhibition of MEK/ERK1/2 signaling affects the fatty acid composition of HepG2 human hepatic cell line

BioImpacts

Volumn 2, Issue 3, 2012, Pages 145-150

  Yousefi, Bahman ^a   Darabi, Masoud ^b,c   Baradaran, Behzad ^c   Khaniani, Mahmoud Shekari ^b   Rahbani, Mohammad ^b   Darabi, Maryam ^d   Fayezi, Shabnam ^a   Mehdizadeh, Amir ^b   Saliani, Negar ^b   Shaaker, Maghsod ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fatty Acids; HepG2 Cells; Liver; MEK ERK1 2; PD98059; Signaling

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACYL COENZYME A DESATURASE; ARACHIDONIC ACID; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MYRISTIC ACID; OLEIC ACID; PALMITOLEIC ACID; POLYUNSATURATED FATTY ACID; STEARIC ACID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID DESATURATION; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID METABOLISM; LIVER CELL CARCINOMA; SIGNAL TRANSDUCTION;

EID: 84876717030     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2012.019     Document Type: Article

References (33)

1. Arendt BM, Mohammed SS, Aghdassi E, Prayitno NR, Ma DW, Nguyen A et al. 2009. Hepatic Fatty Acid Composition Differs Between Chronic Hepatitis C Patients With and Without Steatosis. J Nutr, 139(4), 691-695.
2. BLIGH EG and DYER WJ. 1959. A Rapid Method of Total Lipid Extraction and Purification. Can J Biochem Physiol, 37(8), 911-917.
3. Carter-Kent C, Zein NN and Feldstein AE. 2008. Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis.Implications for Treatment. Am J Gastroenterol, 103(4), 1036-1042.
4. Dobrzyn P, Ntambi JM and Dobrzyn A. 2008. Stearoyl-CoA Desaturase: A Novel Control Point of Lipid Metabolism and Insulin Sensitivity. Eur J Lipid Sci Technol, 110(2), 93-100.
5. Duval C, Auge N, Frisach MF, Casteilla L, Salvayre R and Negre-Salvayre A. 2002. Mitochondrial Oxidative Stress Is Modulated by Oleic Acid Via an Epidermal Growth Factor Receptor-Dependent Activation of Glutathione Peroxidase. Biochem J, 367(Pt 3), 889-894.
6. Furth EE, Sprecher H, Fisher EA, Fleishman HD and Laposata M. 1992. An in Vitro Model for Essential Fatty Acid Deficiency: HepG2 Cells Permanently Maintained in Lipid- Free Medium. J Lipid Res, 33(11), 1719-1726.
7. Green CD, Ozguden-Akkoc CG, Wang Y, Jump DB and Olson LK. 2010. Role of Fatty Acid Elongases in Determination of De Novo Synthesized Monounsaturated Fatty Acid Species. J Lipid Res, 51(7), 1871-1877.
8. Horrobin DF. 1993. Fatty Acid Metabolism in Health and Disease: the Role of Delta-6-Desaturase. Am J Clin Nutr, 57(5 Suppl), 732S-736S.
9. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS et al. 2003. Combined Analysis of Oligonucleotide Microarray Data From Transgenic and Knockout Mice Identifies Direct SREBP Target Genes. Proc Natl Acad Sci U S A, 100(21), 12027-12032.
10. Hu S, Xie Z, Onishi A, Yu X, Jiang L, Lin J et al. 2009. Profiling the Human Protein-DNA Interactome Reveals ERK2 As a Transcriptional Repressor of Interferon Signaling. Cell, 139(3), 610-622.
11. Jennen DG, Magkoufopoulou C, Ketelslegers HB, van Herwijnen MH, Kleinjans JC and van Delft JH. 2010. Comparison of HepG2 and HepaRG by Whole-Genome Gene Expression Analysis for the Purpose of Chemical Hazard Identification. Toxicol Sci, 115(1), 66-79.
12. Jump DB, Botolin D, Wang Y, Xu J and Christian B. 2006. Fatty Acids and Gene Transcription. Scandinavian Journal of Food and Nutrition Research, 50(2), 5-12.
13. Kotzka J, Muller-Wieland D, Koponen A, Njamen D, Kremer L, Roth G et al. 1998. ADD1/SREBP-1c Mediates Insulin- Induced Gene Expression Linked to the MAP Kinase Pathway. Biochem Biophys Res Commun, 249(2), 375-379.
14. Lepage G and Roy CC. 1986. Direct Transesterification of All Classes of Lipids in a One-Step Reaction. J Lipid Res, 27(1), 114-120.
15. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL and Brown MS. 2002. Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice With Selective Deficiency of Sterol Regulatory Element- Binding Protein-1c. J Biol Chem, 277(11), 9520-9528.
16. Mauvoisin D, Prevost M, Ducheix S, Arnaud MP and Mounier C. 2010. Key Role of the ERK1/2 MAPK Pathway in the Transcriptional Regulation of the Stearoyl-CoA Desaturase (SCD1) Gene Expression in Response to Leptin. Mol Cell Endocrinol, 319(1-2), 116-128.
17. Musso G, Gambino R and Cassader M. 2009. Recent Insights into Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). Prog Lipid Res, 48(1), 1-26.
18. Noori M, Darabi M, Rahimipour A, Rahbani M, Abadi NA, Darabi M et al. 2009. Fatty Acid Composition of HDL Phospholipids and Coronary Artery Disease. J Clin Lipidol, 3(1), 39-44.
19. Ntambi JM and Miyazaki M. 2004. Regulation of Stearoyl- CoA Desaturases and Role in Metabolism. Prog Lipid Res, 43(2), 91-104.
20. Pachikian BD, Essaghir A, Demoulin JB, Neyrinck AM, Catry E, De Backer FC et al. 2011. Hepatic N-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets. PLoS One, 6(8), e23365.
21. Portolesi R, Powell BC and Gibson RA. 2008. Delta6 Desaturase MRNA Abundance in HepG2 Cells Is Suppressed by Unsaturated Fatty Acids. Lipids, 43(1), 91-95.
22. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O et al. 2007. A Lipidomic Analysis of Nonalcoholic Fatty Liver Disease. Hepatology, 46(4), 1081-1090.
23. Radenne A, Akpa M, Martel C, Sawadogo S, Mauvoisin D and Mounier C. 2008. Hepatic Regulation of Fatty Acid Synthase by Insulin and T3: Evidence for T3 Genomic and Nongenomic Actions. Am J Physiol Endocrinol Metab, 295(4), E884-E894.
24. Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A et al. 2009. Differential Effect of Oleic and Palmitic Acid on Lipid Accumulation and Apoptosis in Cultured Hepatocytes. J Gastroenterol Hepatol, 24(5), 830-840.
25. Tsai J, Qiu W, Kohen-Avramoglu R and Adeli K. 2007. MEK- ERK Inhibition Corrects the Defect in VLDL Assembly in HepG2 Cells: Potential Role of ERK in VLDL-ApoB100 Particle Assembly. Arterioscler Thromb Vasc Biol, 27(1), 211-218.
26. Turcotte LP, Raney MA and Todd MK. 2005. ERK1/2 Inhibition Prevents Contraction-Induced Increase in Plasma Membrane FAT/CD36 Content and FA Uptake in Rodent Muscle. Acta Physiol Scand, 184(2), 131-139.
27. Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B et al. 2006a. Regulation of Hepatic Fatty Acid Elongase and Desaturase Expression in Diabetes and Obesity. J Lipid Res, 47(9), 2028-2041.
28. Wang Y, Botolin D, Xu J, Christian B, Mitchell E, Jayaprakasam B et al. 2006b. Regulation of Hepatic Fatty Acid Elongase and Desaturase Expression in Diabetes and Obesity. J Lipid Res, 47(9), 2028-2041.
29. Wang Y, Torres-Gonzalez M, Tripathy S, Botolin D, Christian B and Jump DB. 2008. Elevated Hepatic Fatty Acid Elongase- 5 Activity Affects Multiple Pathways Controlling Hepatic Lipid and Carbohydrate Composition. J Lipid Res, 49(7), 1538-1552.
30. Wang Z, Yao T and Song Z. 2010. Involvement and Mechanism of DGAT2 Upregulation in the Pathogenesis of Alcoholic Fatty Liver Disease. J Lipid Res, 51(11), 3158-3165.
31. Zaloga GP and Marik P. 2001. Lipid Modulation and Systemic Inflammation. Crit Care Clin, 17(1), 201-217.
32. Zhu J, Zhang X, Wang C, Peng X and Zhang X. 2009. Periprosthetic Strain Magnitude-Dependent Upregulation of Type I Collagen Synthesis in Human Osteoblasts Through an ERK1/2 Pathway. Int Orthop, 33(5), 1455-1460.
33. Zvibel I, Bar-Zohar D, Kloog Y, Oren R and Reif S. 2008. The Effect of Ras Inhibition on the Proliferation, Apoptosis and Matrix Metalloproteases Activity in Rat Hepatic Stellate Cells. Dig Dis Sci, 53(4), 1048-1053.